Items where Author is "Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana"

dr. Putu Anda Tusta Adiputra, S.Ked, Sp.B (K) Onk., PUTU ANDA TUSTA ADIPUTRA and Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2019) EGFR nanovaccine in lung cancer treatment. Bali Medical Journal, 8 (3). ISSN 2089-1180

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2018) Role of Aromatase Inhibitors in Breast Cancer. In: UNSPECIFIED.

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2018) THE PLACE OF CHEMOTHERAPY IN HORMONE RECEPTOR POSITIVE ADVANCED BREAST CANCER. In: UNSPECIFIED.

dr. I Made Pande Dwipayana, S.Ked., Sp.PD., I MADE PANDE DWIPAYANA and dr. I Made Siswadi Semadi, M.Biomed, Sp.PD, I Made Siswadi Semadi and Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2017) Diagnosis and Management of An Anaplastic Thyroid Cancer Case Report. Biomedical and Pharmacology Journal, 10 (3). ISSN 2456–2610

dr. I. B. Made Suryawisesa, SpB(K)Onk, I. B. Made Suryawisesa and dr. I Gede Budhi Setiawan,Sp.B(K)Onk, I GEDE BUDHI SETIAWAN and Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana and Dr. dr. I Wayan Sudarsa, Sp.B(K)Onk, I Wayan Sudarsa and Prof. Dr. dr.Ida Bagus Tjakra Wibawa Manuaba,MPH, Sp.B(K)Onk,Fin, IDA BAGUS TJAKRA WIBAWA MANUABA and Prof. Dr. Drh. I Gusti Ngurah Kade Mahardika, I GUSTI NGURAH KADE MAHARDIKA (2017) The Correlation between Mammaglobin a mRNA Concentration in Peripheral Blood and Clinical Stages of Breast Cancer Patients at Sanglah General Hospital. International Journal of Science and Research (IJSR), 6 (4). ISSN 2319-7064

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2017) PERAN AROMATASE INHIBITORS PADA KANKER PAYUDARA. In: UNSPECIFIED.

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2017) TRIOSIN KINASE INHIBITOR PADA HER-2 POSITIF KANKER PAYUDARA LANJUT. In: UNSPECIFIED.

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana and dr. NI Gusti Ayu Agung Manik Yuniawaty Wetan, Sp.B. (K)Onk, NI GUSTI AYU AGUNG MANIK YUNIAWATY WETAN and dr. Arif Winata, Sp.B, ARIF WINATA (2017) EKSPRESI TUMOR INFILTRATING LYMPHOCYTES YANG TINGGI SEBAGAI FAKTOR RESIKO RESPON KEMOTERAPI POSITIF PADA PASIEN TRIPLE NEGATIVE BREAST CANCER DI BALI. In: UNSPECIFIED.

Dr. dr. I Wayan Sudarsa, Sp.B(K)Onk, I Wayan Sudarsa and Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana (2017) HUBUNGAN EKSPRESI POLY ADP-RIBOSE POLYMERASE-1 (PARP-1) DENGAN TRIPLE NEGATIVE BREAST CANCER (TNBC) METASTASE REGIONAL. In: UNSPECIFIED.

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana and dr. I. B. Made Suryawisesa, SpB(K)Onk, I. B. Made Suryawisesa (2016) THE ROLE OF LYMPHATIC AND VASCULAR INVASION IN LYMPH NODE METASTASIS IN T1 T2N0 BREAST CANCER PATIENTS AT SANGLAH GENERAL HOSPITAL. INDIAN JOURNAL OF APPLIED RESEARCH, 7 (1). ISSN 2250-0138 (Online)

Dr.dr Ketut Widiana, Sp.B (K).Onk., Ketut Widiana and Prof. Dr. dr.Ida Bagus Tjakra Wibawa Manuaba,MPH, Sp.B(K)Onk,Fin, IDA BAGUS TJAKRA WIBAWA MANUABA and Prof.Dr.dr. I Ketut Siki Kawiyana, SpB. SpOT (K), I KETUT SIKI KAWIYANA and Prof. Dr. dr. I Wayan Putu Sutirta Yasa, M.Si, I WAYAN PUTU SUTIRTA YASA (2015) Changes Of mRNA Caspase-3 After First Cycle Of Chemotherapy As Biomarker Associate To Chemotherapy Negative Response In Locally Advanced Breast Cancer. Bali Medical Journal, 4 (2). ISSN 2089-1180